While low-density lipoprotein cholesterol (LDL-C) management is a central pillar of CVD treatment, many patients continue to ...

Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a significant cause of cardiovascular events. A key process in ...

A world-first drug being developed in WA to cure atherosclerosis could put a major dent in the annual $14.3 billion cost of ...

Atherosclerosis Prevention and Treatment in Children and Adolescents. ... [41,42] The recommended dose of phytosterols for the treatment of dyslipidemia is 2 g/day.

High levels of this protein have been linked to heart disease before, but this is the first time scientists have shown that ...

Research has shown how cells in atherosclerosis share mutational patterns with tumor biology, with a large proportion of the ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis — a primary driver of cardiovascular death worldwide — in large mammals, a study suggests.

DT-109 could help fill a void in effective treatment for fatty liver disease. "In this country, we have more than one-third of the people having fatty liver disease," said Chen.

Pharmaceutical companies are advancing therapies, such as statins and novel anti-inflammatory drugs, to enhance atherosclerosis treatment outcomes. With the global atherosclerosis market segmented ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...